AU8512598A - Oligonuclotides having 3' terminal stereospecific phosphorothioates - Google Patents
Oligonuclotides having 3' terminal stereospecific phosphorothioatesInfo
- Publication number
- AU8512598A AU8512598A AU85125/98A AU8512598A AU8512598A AU 8512598 A AU8512598 A AU 8512598A AU 85125/98 A AU85125/98 A AU 85125/98A AU 8512598 A AU8512598 A AU 8512598A AU 8512598 A AU8512598 A AU 8512598A
- Authority
- AU
- Australia
- Prior art keywords
- oligonuclotides
- stereospecific
- phosphorothioates
- terminal
- terminal stereospecific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 title 1
- 230000000707 stereoselective effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5371897P | 1997-07-25 | 1997-07-25 | |
| US60053718 | 1997-07-25 | ||
| PCT/US1998/015420 WO1999005160A2 (en) | 1997-07-25 | 1998-07-24 | Oligonuclotides having 3' terminal stereospecific phosphorothioates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU8512598A true AU8512598A (en) | 1999-02-16 |
Family
ID=21986075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU85125/98A Abandoned AU8512598A (en) | 1997-07-25 | 1998-07-24 | Oligonuclotides having 3' terminal stereospecific phosphorothioates |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU8512598A (en) |
| WO (1) | WO1999005160A2 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6242589B1 (en) | 1998-07-14 | 2001-06-05 | Isis Pharmaceuticals, Inc. | Phosphorothioate oligonucleotides having modified internucleoside linkages |
| US6867294B1 (en) | 1998-07-14 | 2005-03-15 | Isis Pharmaceuticals, Inc. | Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages |
| EP2370451B1 (en) | 2008-12-02 | 2016-11-16 | Wave Life Sciences Japan, Inc. | Method for the synthesis of phosphorus atom modified nucleic acids |
| KR101885383B1 (en) | 2009-07-06 | 2018-08-03 | 웨이브 라이프 사이언시스 리미티드 | Novel nucleic acid prodrugs and methods of use thereof |
| US10428019B2 (en) | 2010-09-24 | 2019-10-01 | Wave Life Sciences Ltd. | Chiral auxiliaries |
| EP2734208B1 (en) | 2011-07-19 | 2017-03-01 | Wave Life Sciences Ltd. | Methods for the synthesis of functionalized nucleic acids |
| PL2872485T3 (en) | 2012-07-13 | 2021-05-31 | Wave Life Sciences Ltd. | Asymmetric auxiliary group |
| CN104661664B (en) | 2012-07-13 | 2020-07-03 | 波涛生命科学有限公司 | Chiral control |
| CA2879066C (en) | 2012-07-13 | 2019-08-13 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant |
| WO2015108047A1 (en) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator |
| JPWO2015108046A1 (en) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | Chiral nucleic acid adjuvant and antiallergic agent having antiallergic action |
| JPWO2015108048A1 (en) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | Chiral nucleic acid adjuvant and antitumor agent having antitumor activity |
| EP4137572A1 (en) | 2014-01-16 | 2023-02-22 | Wave Life Sciences Ltd. | Chiral design |
| MA43072A (en) | 2015-07-22 | 2018-05-30 | Wave Life Sciences Ltd | COMPOSITIONS OF OLIGONUCLEOTIDES AND RELATED PROCESSES |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4521509A (en) * | 1982-11-24 | 1985-06-04 | Research Corporation | Method for degrading DNA |
| US4924624A (en) * | 1987-10-22 | 1990-05-15 | Temple University-Of The Commonwealth System Of Higher Education | 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof |
| WO1989005358A1 (en) * | 1987-11-30 | 1989-06-15 | University Of Iowa Research Foundation | Dna and rna molecules stabilized by modifications of the 3'-terminal phosphodiester linkage and their use as nucleic acid probes and as therapeutic agents to block the expression of specifically targeted genes |
| JP2693643B2 (en) * | 1991-10-15 | 1997-12-24 | アイシス・ファーマシューティカルス・インコーポレーテッド | Oligonucleotide with chiral phosphorus bond |
| CA2208528A1 (en) * | 1994-12-22 | 1996-06-27 | Hybridon, Inc. | Synthesis of stereospecific oligonucleotide phosphorothioates |
| JPH10510433A (en) * | 1995-06-06 | 1998-10-13 | アイシス・ファーマシューティカルス・インコーポレーテッド | Oligonucleotides with high chiral purity phosphorothioate linkages |
-
1998
- 1998-07-24 WO PCT/US1998/015420 patent/WO1999005160A2/en not_active Ceased
- 1998-07-24 AU AU85125/98A patent/AU8512598A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999005160A3 (en) | 1999-04-08 |
| WO1999005160A2 (en) | 1999-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0676828A3 (en) | Connector | |
| AU3303595A (en) | Capillary connector | |
| AU5773198A (en) | Can ends | |
| AU6936098A (en) | Connector | |
| AU8512598A (en) | Oligonuclotides having 3' terminal stereospecific phosphorothioates | |
| AU5670498A (en) | Connector | |
| AU4101097A (en) | Offset connector | |
| AU7059298A (en) | Can end | |
| AU7170798A (en) | Antithrombotic agents | |
| AU6525998A (en) | Improved metallo-endopeptidases | |
| AU1346199A (en) | Connector | |
| AU2969997A (en) | Connector | |
| AU1870897A (en) | Connector | |
| AU718511C (en) | Glyphosate liquid formulations | |
| DE69908936D1 (en) | 2''-deoxyhygromycinderivate | |
| AU7274098A (en) | Antithrombotic agents | |
| AU2049997A (en) | Enhanced flavors using 2'-hydroxypropiophenone | |
| AU7170898A (en) | Antithrombotic agents | |
| AU7563598A (en) | Antithrombotic agents | |
| AUPO699597A0 (en) | Hill's adapta-line | |
| GB9621627D0 (en) | User 'tuneable' Skibob | |
| AUPO782497A0 (en) | Dagianda project 3 fouroctagonal | |
| AUPP232098A0 (en) | Sensacam 101 | |
| AUPP662198A0 (en) | Stripakote 2000 | |
| AUPO482697A0 (en) | The "Ad-light" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |